INTRODUCTION
Gastric inhibitory peptide (GIP) is a 42 amino acid regulatory peptide produced by specific endocrine cells (K cells) in the proximal small intestine (Buffa et al. 1975 ). The amino acid sequences of porcine (Jornvall et al. 1981; Moody et al. 1981) , bovine (Carlquist et al. 1984) and human (Moody et al. 1984) GIP are known; each is 42 amino acids in length and the sequences are highly conserved. The sequence of GIP indicates that it is a member of a family of related peptides which includes secretin, glucagon, vasoactive intestinal polypeptide, growth hormone-releasing factor, peptide histidine isoleucine and pituitary adenyl cyclase-activating protein (Bell, 1986; Miyata et al. 1989) . Despite the fact that GIP was first isolated on the basis of its ability to inhibit histamine-stimulated gastric acid secretion (Brown et al. 1969) , the physiological role of GIP remains unclear, as this inhibitory effect is limited (Maxwell et al. 1980) . GIP is also known as glucosedependent insulinotropic polypeptide, on the basis of its ability to enhance insulin release in the pres¬ ence of elevated levels of plasma glucose (Dupre et al. 1973; Pederson et al. 1975 ; Pederson & Brown, 1976; Andersen et al. 1978 ). This effect is seen at physiological levels of GIP and it has been suggested that GIP forms a component of the incretin effect.
It has also been suggested that GIP may play an important role in regulating glucagon secretion from pancreatic alpha cells (Opara & Go, 1991) . GIP may therefore influence glucose homeostasis at a number of levels.
Little is known about the regulation of GIP bio¬ synthesis. The structure of the precursor protein is known in man (Takeda et i   61   121  181  241  301  361  421  481  541  601   CTGTTTGGAG   TGGAAGAGCT  AGACCTGCTC  AGGTTGAGTT  CAGAGGGGAC  TTGTGAACTG  AGAGAGAGGC  CACAGGGGAG  TTCAAGAGCT  GACCGACCTA  GCCCTGGTCC   CAAGATCCTG   AAGAAGAGCT   TCTGCTGCTG   CCGATCCCAT  TTTCATCAGT  GCTTCTGGCC  CCGGGCTTTG  CTCTTTGCCC  ACTGGCCTGG  CCCCGGAGCA   AAAGTCTCTG   AGAACCAACA  GTTGGCTCGG  GTGCTCCTGT  GCTAAATTTG   GATTACAGCA  CAGAAGGGGA   GAGCTGGCAG  AAGAGCCTCA  ATGGCGGACC  GGACTGGACT   AGAGAACCAA   GGTAGACGAA   GGACACAATC   TCCTGGCTGT  CTGGCCCCCG  TCGCCATGGA  AGAAGAATGA  GACAATCTCA  GTGATGAAGA   AAGCAGAGCT   CTGACCTTAG   ACCAATAAAG   GGGACCTCAT  TAGGAAGATG  CGGGCTGGGA  ACCACGAGGC  CAAGATCCGC  CTGGAAACAC  GAGAAACGAG   TGTGCTGAGG  CTGTCGACTG   CTTGCTCAGA  CCTTGAGCTG   CCTGCCCTCC   GTGGCTTTGA   GAAAAAGAAG   CCAAGGTATG  CAACAAGACT  AACCTCACCC  GAGAAAGAGG  GACCTTCTGA  AGGTCCCAGT  TCCTGCTTCT (Heery et al. 1990 ) and ethanol-precipitated. After digestion with EcoRI, the DNA was cloned into Ml3 mpl8 and recombinants were prepared for sequencing using standard techniques (Sambrook et al. 1989) . Sequencing was performed using the extended Klenow chain-termination method (Stambaugh & Blakesley, 1988) .
Amplification of cDNA ends The rest of the GIP cDNA was amplified using an anchor PCR technique, essentially as described by Frohman et al. (1988) . The strategy and primers are indicated in Fig. 1 .
For the 3' end, mRNA was reverse-transcribed and amplified as above, but using oligo(dT) to prime reverse transcription. Primers for the first round of 3' amplification were 5'M (120 pg/ml) and linker-dT primer (LdT: GTGGAATTCTCGAGTCGACT TTTTTTTTTT, 2-5 pg/ml). Amplification condi¬ tions were as above except that annealing was for 3 min. A tenfold dilution of this reaction (20 pi) was then amplified using the 5' specific primer (5'S, 7-5 pg/ml) and LdT (2-5 pg/ml) with reaction condi¬ tions as above. (2-5 pg/ml), and for the second round 3' specific primer (3'S, 7-5 pg/ml) and LdT (2-5 pg/ml).
Cloning and sequencing of cDNA ends PCR reaction products (10 pi) were fractionated on a 1% agarose gel, blotted and hybridized with the GIP-coding-sequence probe. Regions correspond¬ ing to the hybridizing region were then eluted from a gel containing the remainder of the reaction, digested with EcoRI and cloned into Ml3 as for the GIP-coding region. Plaques containing the GIP cDNA ends were identified by plaque-lift hybridiza¬ tion using the coding-region probe. Sequencing was as above for the 3' end, but was performed following a protocol using Taq DNA polymerase for the 5' end (Brow, 1990 (Fig. le) . Four independent clones were analysed, but these differed only in orientation and in the number of adenosine residues in the poly(A) tail. For the 5'-end amplification, duodenal mRNA was reverse-transcribed with random primers. After removal of excess primers and nucleotides, a poly(A) tail was added using terminal transferase. The tailed cDNA was then amplified using the same strategy as had been used for the 3' end (Fig. la) . On Southern blotting, GIP-specific products were seen at about 350 bp, with some hybridization to a diffuse region representing shorter products. The major species was eluted, cloned and sequenced as for the 3' end. Five clones were sequenced and showed length het¬ erogeneity at the 5' end, indicating a problem in the generation of full-length cDNAs. The first 12 bases were derived from one clone only and may therefore be subject to PCR errors. The cDNA sequence of 654 bases is shown in Fig. lb . There was an ATG triplet at position 108 followed by an open reading frame of 144 amino acids which included the sequence of GIP itself (amino acids 44-85).
The distribution of rat GIP mRNA was studied by using the cloned 3'-end cDNA as a probe for Northern blots of rat tissues. Within the gastrointes¬ tinal tract, expression was detected at high levels in the duodenum and jejunum, with no signals in other regions (Fig. 2a) (Fig. 26) , and that it could be detected with the probes for the GIP-coding sequence and the 5'-end sequence described above (not shown). Finally, as we intend to use the GIP probe in rat models of diabetes, we wished to demonstrate that the expres¬ sion of the GIP gene responded to physiological changes. It is known that rat duodenal GIP peptide levels are elevated after starvation (Shulkes et al. 1983 ). We measured GIP mRNA levels in the duo¬ denum after a period of 2 days of starvation and found double the level of GIP mRNA in the starved group using the 5'-end probe (Fig. 3) . The figure for the control group (mean ± s.d.) was 5-22 ±0-98 and that for the starved group was 10-42±l-83 (P = 00039; Mann-Whitney U/Wilcoxon rank sum test, two-tailed). The blot was stripped and reprobed with the 3'-end probe, to check that the full cDNA sequence was represented in the band, and identical results were obtained (Fig. 3) . DISCUSSION We have characterized cDNA encoding the pre¬ cursor of rat GIP using the combination of mixed primer and anchor PCR developed in this laboratory during the cloning of neuromedin U (Lo et al. 1992 ). This approach is particularly appropriate for the study of regulatory peptide cDNAs. Conservation between species of short, biologically active regions means that mixed-sequence PCR primers can be used to amplify cDNAs from a variety of species. Having determined the nucleotide sequence between the mixed primers, this sequence can then be used to design primers for anchor PCR, enabling a longer sequence to be isolated. However, this approach has the disadvantage that it is necessary to sequence a number of independent clones to guard against the possibility of PCR errors. In current studies we are using direct sequencing of PCR products to bypass this problem and to shorten the procedure further. With long cDNAs, the alternative of isolating a con¬ ventional cDNA clone might be preferable. The nucleotide sequence of rat preproGIP and the corresponding deduced amino acid sequence are shown in Fig. 16 (Fig. 3) . This might have indicated the induction of a novel type of GIP-related mRNA, as has been seen, for instance, in the calcitonin/calcitonin generelated peptide gene (Amara et al. 1982) . However, we reprobed the blot with the 3' GIP cDNA probe and observed the same effect, ruling out the possib¬ ility of a second mRNA sharing only N-terminal coding sequences with GIP mRNA. We have not investigated this phenomenon further; it may be caused by heterogeneity in the length of the poly(A) tail, although other possibilities clearly exist. Com¬ parison of the amino acid sequence with that of human preproGIP shows a very similar structure (Fig. 1c) . As in man, the rat precursor protein has a hydrophobic signal peptide with a probable cleavage site at glycine-21. The remaining proGIP consists of GIP itself, with N-and C-terminal flanking pep¬ tides of 22 and 59 amino acids respectively. The sequence indicates that rat GIP, like its human equivalent (Takeda et al. 1987) , is released from its precursor by cleavage at single arginine residues. Like its porcine, bovine and human equivalents, rat GIP is 42 amino acids in length. Rat GIP differs from the others in just two (human and porcine) or three (bovine) amino acids (Fig. 1c) . There is 63% homology between the rat and human N-terminal flanking peptides, though optimal alignment requires the deletion of eight amino acids from the human sequence. The rat C-terminal flanking pep¬ tide is 59 amino acids in length compared with 60 in man, and there is 71% homology between the two, including a region of 16 amino acids with only a single conservative replacement. This level of con¬ servation suggests a significant function for this region, perhaps in the processing of the precursor, or possibly as an independently secreted peptide.
In the case of the pro-opiomelanocortin gene, different peptides are produced by different cell types (Hinman & Herbert, 1980; Rosa et al. 1980 (Fig. 2a) . Although duodenum and jejunum are the regions containing most immunoreactive GIP (Polak et al. 1973; Buffa et al. 1975 ), smaller amounts have been reported in the stomach, ileum and colon (O'Dorisio et al. 1977; Alumets et al. 1978) . How¬ ever, in our studies, GIP mRNA was not detected in these tissues (Fig. 2 ).
There have also been reports of GIP-like immunoreactivity in the pancreas (Smith et al. 1977; Alumets et al. 1978; Erlandsen, 1980; Ähren et al. 1981) . However, Sarson (1982) reported that no GIP peptide could be extracted from the pancreas, and other workers were unable to detect pancreatic GIPlike immunoreactivity (Larsson 8c Moody, 1980; Buchan et al. 1982 (Fig. 2b) . Of the known members of the GIP/glucagon gene family, GIP mRNA is closest in sequence to glucagon mRNA itself, with 64% homology over an 87 base region. However, the cross-hybridizing RNA seen in the pancreas is clearly not glucagon mRNA (Fig. 2b) . Further studies will be required to elucidate the nature of this species, which may represent a further member of the glucagon gene family.
